
that both procedures have similar midterm outcomes.
However, long-term outcomes continue to favor CEA
because of its lower periprocedural stroke and death
rate. In addition, 10-year outcomes comparing CEA and
transfemoral CAS have been published. In symptomatic
patients from CREST, a combined end point of periprocedural stroke and death and 10-year ipsilateral stroke was
7.9% (95% CI, 5.